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Nationwide study of haemolytic uraemic syndrome:
clinical, microbiological, and epidemiological
features
E J Elliott, R M Robins-Browne, E V O’Loughlin, V Bennett-Wood, J Bourke, P Henning,
G G Hogg, J Knight, H Powell, D Redmond, Contributors to the Australian Paediatric
Surveillance Unit
Abstract
Aims—To establish the incidence and
aetiology of haemolytic uraemic syn-
drome (HUS) in Australia and compare
clinical and microbial characteristics of
sporadic and outbreak cases.
Methods—National active surveillance
through the Australian Paediatric Sur-
veillance Unit with monthly case notifica-
tion from paediatricians, July 1994 to June
1998. Children under 15 years presenting
with microangiopathic haemolytic anae-
mia, thrombocytopenia, and acute renal
impairment were identified.
Results—Ninety eight cases were identi-
fied (incidence 0.64 per 105 children <15
years/annum and 1.35 per 105 children <5
years/annum). Eighty four were associated
with diarrhoea (64 sporadic, 20 constitut-
ing an outbreak) and 14 were atypical.
Shiga toxin producing Escherichia coli
(STEC) O111:H− was the most common
isolate in sporadic HUS and caused the
outbreak. However O111:H− isolates from
outbreak and sporadic cases diVered in
phage type and subtyping by DNA electro-
phoresis. STEC isolates from sporadic
cases included O26:H−, O113:H21,
O130:H11, OR:H9, O157:H−, ONT:H7,
and ONT:H−. STEC O157:H7 was not iso-
lated from any case.Only O111:H− isolates
produced both Shiga toxins 1 and 2 and
possessed genes encoding E coli attaching
and eVacing gene (intimin) and enterohe-
molysin.Outbreak cases had worse gastro-
intestinal and renal disease at presentation
and more extrarenal complications.
Conclusions—Linking national surveil-
lance with a specialised laboratory service
allowed estimation of HUS incidence and
provided information on its aetiology. In
contrast to North America, Japan, and the
British Isles, STEC O157:H7 is rare in
Australia; however, non-O157:H7 STEC
cause severe disease including outbreaks.
Disease severity in outbreak cases may
relate to yet unidentified virulence factors
of the O111:H− strain isolated.
(Arch Dis Child 2001;85:125–131)
Keywords: Shiga toxin; E coli; haemolytic uraemic
sydrome; surveillance
Haemolytic uraemic syndrome (HUS) is char-
acterised by microangiopathic haemolytic
anaemia, thrombocytopenia, and acute renal
impairment. It is usually preceded by diar-
rhoea, often bloody. Karmali et al first identi-
fied the association between HUS and infec-
tion with Shiga toxin producing Escherichia coli
(STEC) O157:H7 in children,1 2 which is now
well established.3–7 STEC were previously
known as verotoxin producing E coli. In North
America and Europe most HUS is caused by
STEC of serotype O157:H7 and major out-
breaks have occurred following ingestion of
contaminated food or drink, swimming in con-
taminated water, contact with farm animals,
through environmental contamination, or per-
son to person spread.8–17 While the major cause
of infection in humans is STEC O157:H7,
other serotypes also may cause diarrhoea and
HUS.18–21 DiVerences in the occurrence of
STEC serotypes appear to be geographic; data
suggest non-O157:H7 STEC strains predomi-
nate in Australia22–24 and contribute to disease
in several other countries.18 20 21 25 Although
typically associated with intestinal infection,
HUS may also follow urinary tract infection
with STEC26 or systemic infection with neu-
raminidase producing bacteria.27 HUS may be
familial28 or associated with immunodeficiency,
immunosuppression, and pregnancy.29
The epidemiology of HUS in the southern
hemisphere is poorly described. Although diar-
rhoea associated HUS occurs in Australia,
STEC O157:H7 has rarely been implicated.
This may reflect the fact that diagnostic labora-
tories do not routinely test for this STEC in
patients with diarrhoea or may indicate that
HUS in Australia is caused by diVerent STEC
than are commonly implicated in Europe and
North America. The frequency of STEC associ-
ated disease in Australia is unknown. We under-
took nationwide surveillance of HUS, as a
marker of STEC related disease, through the
Australian Paediatric Surveillance Unit
(APSU).30 Study aims were to determine the
incidence, demographic, and clinical character-
istics of HUS and to examine the aetiological
role of STEC. During surveillance the first
major outbreak of HUS in Australia oc-
curred,31 32 providing a unique opportunity to
compare clinical, epidemiological, and micro-
biological characteristics of sporadic and out-
break HUS.
Methods
CASE ASCERTAINMENT, CASE DEFINITION, AND
CASE CLASSIFICATION
Cases were ascertained prospectively through
the APSU by active, national surveillance
between July 1994 and June 1998 inclusive.30
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All paediatric specialists in Australia were sent
a monthly, reply paid report card and asked to
indicate whether they had seen any child under
15 years of age in the previous month with any
of the conditions listed on the card, including
HUS. HUS was defined as “microangiopathic
haemolytic anaemia (haemoglobin <100 g/l
with microscopic evidence of fragmented red
blood cells), thrombocytopenia (platelet count
<100 000 × 109), and acute renal impairment
(oliguria or anuria with increased serum urea
and creatinine)”. During the study period over
900 clinicians were mailed and over 93%
report cards were returned to the APSU each
month. The APSU notified study investigators
of reported cases of HUS each month. Investi-
gators obtained further information on indi-
vidual cases (clinical presentation, outcome,
demographics, and laboratory results) from
clinicians notifying cases by standardised
postal questionnaire (96% of questionnaires
were returned). Data provided was de-
identified to maintain patient anonymity. Diar-
rhoea associated cases of HUS were classified
as “sporadic” or “outbreak” cases. The single
outbreak consisted of cases occurring in South
Australia in January and February 1995 and in
whom a common causative organism was sub-
sequently confirmed. Cases with no significant
gastrointestinal disease or isolation of STEC in
the stool and with a family history of HUS,
with an atypical or relapsing course or with
confirmed systemic infection with a neuramini-
dase producing organism, were classified as
“atypical”. The ethics committee of the
Children’s Hospital at Westmead, Sydney
approved the study.
MICROBIOLOGY
Clinicians reporting cases were asked to send
paired serum samples and a stool sample or
rectal swab and E coli isolates from faeces or
implicated food, if available, to a centralised
laboratory for isolation and characterisation of
STEC isolates. Colonies from stool specimens,
obtained as soon as possible after the diagnosis
of HUS and cultured on MacConkey agar,
were tested for production of Shiga toxin (Stx)
using HeLa cells.26 33 Stx1 or Stx2 was
identified by neutralisation with monoclonal
antibodies. Colony and Southern blotting was
used to probe STEC isolates for genes encod-
ing virulence associated factors, namely Stx1,
Stx2, E coli attaching and eVacing gene (eae,
intimin), and enterohemolysin.33 Serotyping of
STEC strains was performed at the Victorian
Infectious Diseases Reference Laboratory.34
The relatedness of O111:H− isolates from out-
break and sporadic cases was investigated by
pulsed field gel electrophoresis (PFGE) as
described previously.26 The DNA patterns
obtained were aligned with the aid of Gel
Compar software (Applied Maths, Kortrijk,
Belgium) to form a composite image, and were
analysed as recommended by Tenover and col-
leagues.35 Paired serum samples (acute and
convalescent, collected approximately two
weeks apart) were tested for agglutinating anti-
bodies to O antigens 26, 111, and 157.36
Detailed microbiological data on outbreak
cases have been reported elsewhere.23
ANALYSIS OF DATA
Incidence estimates and confidence intervals
were calculated using Stat-Exact. Comparison
of outbreak and sporadic groups was made
using Student’s t test, Mann–Whitney U test,
and ÷2 or Fisher’s exact tests. Incidence trends
were analysed using the Cochran–Armitage
trend.37
Results
CATEGORISATION OF CASES, INCIDENCE,
SEASONAL, AND GEOGRAPHIC DISTRIBUTION
In a 48 month period, 98 cases of HUS were
identified, of which 84 (86%) were associated
with gastrointestinal symptoms. Sixty four were
sporadic cases and 20 comprised a single
outbreak in South Australia occurring in Janu-
ary and February 1995.31 32 Fourteen “atypi-
cal” cases were identified, of whom five had an
atypical or relapsing course, four were familial,
three were associated with pneumococcal
infection, one was associated with immuno-
deficiency, and one had an STEC associated
urinary tract infection.26 The median age of
cases at diagnosis was 31 months (interquartile
range 16–70 months) and 70/98 (71%) chil-
dren were under 5 years of age. Ninety one
(92%) children were hospitalised for a median
(interquartile range) of 14 (7–21) days.
The reported annual incidence of HUS
(with 95% CI) was 0.64 (0.52 to 0.78) per 105
children under 15 years. Incidence was signifi-
cantly higher in children under 5 years (1.35
(1.06 to 1.72) per 105) than in those aged 5–14
years (0.28 (0.18 to 0.39) per 105; Fisher’s
exact test, p < 0.0001). When outbreak cases
were excluded from the analysis, the overall
incidence was slightly, though not significantly
lower.
Figure 1 shows the distribution of cases by
type and month of presentation. During the
entire study period there was a significantly
higher incidence of cases during summer
months (÷2 test for trend, p < 0.001). This sea-
sonal distribution persisted when outbreak and
atypical cases were excluded. However, when
the data were analysed by individual year of
occurrence, a significant increase in sporadic
cases in the summer only occurred in 1994–95,
at the time of the outbreak. All sporadic cases
Figure 1 Seasonal distribution of HUS cases by type: July 1994 to June 1998 (n = 98).
Incidence of sporadic HUS decreased significantly over the study period (p < 0.001;
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occurring during this time period were micro-
biologically distinct from outbreak cases.
There was a significant trend in the incidence
of sporadic HUS, which decreased over the
four year study period (÷2 test for trend,
p < 0.001). During the entire study period
none of the sporadic cases was associated with
another sporadic case.
COMPARISON OF OUTBREAK AND SPORADIC CASES
WITH DIARRHOEA
Table 1 shows laboratory and clinical features
of children with diarrhoea associated HUS.
The outbreak group was significantly older
than the sporadic group and the proportion of
children under 5 years was lower. There was no
gender bias. Duration of hospitalisation was
significantly longer in the outbreak group.
The minimum haemoglobin and maximum
neutrophil counts were not significantly diVer-
ent between groups (table 1). Maximum serum
creatinine was significantly higher in the
outbreak group and minimum platelet count
and minimum serum sodium concentrations
were significantly lower in the outbreak group.
Eighty per cent of outbreak and 48% of spo-
radic cases developed anuria; its duration was
significantly longer in the outbreak group
(table 1). Significantly more outbreak cases
required dialysis and the duration of dialysis
was significantly longer in the outbreak group.
The frequency of acute hypertension in groups
did not diVer. However, at discharge from hos-
pital a significantly greater proportion of the
outbreak group had persistent renal impair-
ment (increased serum creatinine) and hyper-
tension requiring treatment (table 1).
Although a diarrhoea prodrome was present
in all 84 children, outbreak cases had a shorter
prodrome and a much higher rate of macro-
scopic bloody diarrhoea (table 1). In outbreak
cases the diarrhoea prodrome lasted between
one and seven days and in sporadic cases, one
to 30 days. Significantly more outbreak cases
had severe haemorrhagic colitis. Left hemi-
colectomy was required in one outbreak case
with ischaemic colon and partial colectomy in
another. One sporadic case required appendi-
cectomy and omentectomy. Vomiting was
reported in around 80% of both groups.
Acute pancreatitis occurred in one outbreak
case and hyperglycaemia was significantly
more frequent in the outbreak group (table 1).
Insulin was required in two outbreak cases and
one sporadic case. The proportion of children
with central nervous system complications
(intracranial bleed or infarct, retinal haemor-
rhage, encephalopathy, seizure) was higher in
the outbreak group. One sporadic case had
anterior compartment syndrome caused by
rhabdomyolysis and required fasciotomy of the
right leg. An iliac vein thrombosis occurred in
one child in the outbreak group.
Three of 84 patients died (table 1). A 4 year
old girl with outbreak HUS and acute renal
failure, multiple cerebral haemorrhagic inf-
arcts, and extensive colonic necrosis died two
days after diagnosis. A 10 year old boy with
sporadic HUS and STEC O111 in the stool
died eight days after diagnosis, from cardiac
complications (myocarditis with pericardial
eVusion and tamponade). A 1 year old boy with
sporadic HUS died within 12 months of diag-
nosis with persistent hypertension and renal
failure.
OUTCOME
Twelve month follow up data were available on
all 19 survivors of the outbreak and 43 of 62
survivors of sporadic HUS. Six of 19 outbreak
cases and four of 43 sporadic cases had chronic
renal failure (persistent elevation of creatinine
and/or glomerular filtration rate of <80 ml/
min/1.73 m2) at follow up (p = 0.06). Hyper-
tension persisted at 12 months in four sporadic
but no outbreak cases. No survivors of the out-
break developed end stage renal failure,
defined as requiring chronic dialysis (whether
or not awaiting transplantation) or having had
renal transplantation. Of the three sporadic
cases that developed end stage renal failure by
12 months after diagnosis, one had had a
kidney transplant, one was awaiting transplan-
tation, and one had died. One sporadic case
had persistent insulin dependent diabetes mel-
litus. Five children with sporadic HUS had sei-
zures at follow up. Three of these developed
seizures following discharge from hospital, so
their aetiological relation to HUS is unclear.
MICROBIOLOGY
Stool and/or serum samples were available
from all outbreak cases. STEC serotype
O111:H− was isolated from 16/20 stools from








Minimum haemoglobin (median; g/l) 73 (62–82) 62 (52–73) 0.06
Minimum platelet count (median; × 109/l) 29 (23–44) 56 (28–96) <0.01m
Maximum neutrophil count (median; ×
105/l)
9.3 (7.3–23.7) 8.6 (5.2–12.6) 0.05
Minimum serum sodium (mean; mmol/l) 128 (4) 131 (6) <0.05t




Age (median; mth) 63 (34–99) 30 (18–57) <0.05m
Age less than 5 years (n; %) 9 (45%) 49 (77%) <0.05c
Duration hospital stay (median; days) 17 (10–22) 12 (7–17) <0.01m
Renal features
Anuria (n; %) 16 (80%) 31 (48%) <0.05c
Duration anuria (median; days) 14 (10–20) 5.0 (3–9) <0.001m
Dialysis (n; %) 18 (90%) 35 (55%) <0.01c
Duration dialysis (mean; days) 14.8 (8.1) 10.2 (6.3) <0.05t
Acute hypertension (n; %) 13 (65%) 25 (40%) 0.07
Elevated creatinine at discharge (n; %) 17(85%) 12 (19%) <0.0001c
Hypertension at discharge (n; %) 9 (45%) 12 (20%) <0.05c
Gastrointestinal features
Diarrhoea prodrome (n; %) 20 (100%) 64 (100%)
Duration diarrhoea (median; days) 3.0 (2.0–4.3) 5.0 (4.0–10.0) <0.01m
Blood in stool (n; %) 16 (84%) 23 (36%) <0.001c
Severe colitis (n; %) 6 (27%) 2 (3%) <0.01f
Vomiting (n; %) 17 (85%) 50 (78%) 0.75
Acute pancreatitis (n; %) 1 (5%) 0 (0%) 0.24
Other
Seizures (n; %) 5 (25%) 7 (11%) 0.18
Central nervous system events* 9 (45%) 8 (13%) <0.001c
Hyperglycaemia 5 (25) 3 (5%) <0.05f
Death <12 months after diagnosis 1 (5%)† 2 (3%)‡§ 0.42
Results are shown as n (%), mean (SD), or median (interquartile range).
Comparison between outbreak and sporadic HUS was made using: tStudent’s t test;
mMann–Whitney U test; c÷2 test; fFisher’s exact test.
*Includes children with one or more of the following: seizure, intracranial haemorrhage or infarct,
retinal haemorrhage, encephalopathy.
Death was due to: †multiple cerebral haemorrhagic infarction; ‡myocarditis with pericardial eVu-
sion; §complications of renal failure.
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these children.23 Stool specimens or bacterial
cultures were investigated from 50/64 children
with sporadic HUS. STEC were isolated from
20/50 specimens (table 2). These included
strains of serotypes O111:H−, O26:H−,
O113:H21, O130:H11, O157:H−, O non-
typeable:H−, O non-typeable:H7, and O rough
(R):H9. All isolates fermented sorbitol except
those of serogroup O157 (table 2). One child
was infected with both STEC OR:H9 and an
Stx2 producing strain of Enterobacter cloacae.38
STEC O111:H− was also isolated from the
stool of the asymptomatic identical twin
brother of a culture negative case of endemic
HUS.39 The high number (30/50) of negative
stool cultures in sporadic cases is not surprising
in view of the long diarrhoea prodrome (up to
30 days) prior to diagnosis of some cases in this
group.
Table 2 shows virulence associated charac-
teristics of STEC isolates. All O111:H− strains
from outbreak and sporadic cases produced
Stx1 and Stx2 and carried the eae and entero-
hemolysin genes. However, PFGE analysis of
the outbreak and sporadic O111:H− strains
showed them to be diVerent (fig 2). Further-
more, some O111:H− strains obtained from
children with HUS in New South Wales
around the time of the South Australian
outbreak displayed a diVerent phage type, col-
icin type and had diVerent plasmid profiles
compared to the epidemic strain.39 Of the non-
O111:H− strains isolated and examined for the
presence of virulence associated factors, all but
three carried the enterohemolysin gene and
produced enterohemolysin (table 2). Two of
the strains that did not produce enterohemo-
lysin were of indeterminate serotype and
produced only Stx1 or Stx2. All non-O111
STEC produced either Stx1 or Stx2 but only
one produced both. Five strains did not carry
the eae gene. One sporadic case without STEC
infection had a Salmonella species, one Salmo-
nella plus Giardia lamblia, and two Campylo-
bacter jejuni in the stool. The STEC O5:H−
isolate from an atypical case with urinary tract
infection produced Stx1 and Stx2 and carried
the gene for enterohemolysin but not that for
eae.26
Serum was available from 30 children with
sporadic HUS, but as only one serum sample
was available from most cases, we selected a
high agglutinating antibody titre (>1/640) to
indicate recent infection with E coli strains of
serogroups O26, O111, or O157. Five patients
showed increased antibody to O157, one of
whom was also culture positive for STEC
O157:H−. All 25 other sera investigated for
antibodies to serogroup O157 showed a titre of
<1/80. Three patients who were culture
positive for STEC O111: H−, had an antibody
titre to O111 of >1/640. The other five O111
culture positive patients identified in this study
did not undergo serological examination. One
patient with negative stool culture had a titre of
>1/2560 to O111. No patient showed in-
creased antibody titres to O26.
Discussion
The epidemiology of HUS in Australia has not
been described previously. Four years of
national surveillance through the APSU identi-
fied 98 patients under 15 years of age with
HUS. Approximately 90% had diarrhoea asso-
ciated HUS and 20 were aVected during an
outbreak of STEC O111:H− transmitted by
contaminated mettwurst. Diarrhoea associated
HUS was associated with at least eight diVerent
STEC serotypes. Although up to seven cases
were associated with STEC O157, no strains of
O157:H7 were isolated, indicating major geo-
graphical diVerences in strain prevalence
Table 2 Characteristics of STEC isolates in diarrhoea associated HUS
Presence of virulence associated factors
No. of isolates Serotype
Sorbitol
fermentation Stx1† Stx2† eae Enterohaemolysin
Outbreak HUS*
16 O111:H− + + + + +
Sporadic HUS
8 O111:H− + + + + +
1 O26:H− + + − + +
4 O113:H21 + − + − +
1 O130:H11 + − + − +
1 O157:H− − + + + −
1 O157:H− − − + + +
1 O157:H−‡ ? ? ? ? ?
1 ONT:H− + − + − −
1 ONT:H7 + − + − +
1§ OR:H9 + + − − −
Specimens were investigated on 20/20 epidemic cases and 50/64 endemic cases.
*Paton et al.23
†Shiga toxin produced and Shiga toxin genes present (+) or absent (−).
‡Virulence associated features not determined on this isolate.
§Obtained from a patient who was also infected with a Shiga toxin 2 producing strain of Entero-
bacter cloacae.38
NT, non-typeable; R, rough.
Figure 2 Composite image of PFGE of whole cell DNA
from serogroup O111 isolates of E coli digested with XbaI.
Lane 1, PFGE marker I (Boehringer Mannheim); lane 2,
outbreak case; lanes 3–7, sporadic cases.Molecular weights
of the markers are indicated on the left.
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worldwide. Comparison of clinical features of
sporadic and outbreak cases of HUS suggests
the outbreak strain caused more severe disease
at presentation, although specific microbial
factors accounting for these diVerences were
not identified.
The active nature of the surveillance, high
return rate of monthly report cards and
questionnaires, and inclusion on our mailing
list of all known paediatric specialists in
Australia, suggest that we identified the major-
ity of HUS cases. No other national data set is
available for comparison. The incidence of
HUS in children under 5 years (1.35 (95% CI
1.06 to 1.72) per 105) was lower than that
reported in Canada (3.11 per 105 children <5
years)3 and the British Isles (3.3 per 105
children).4 In Minnesota the incidence of HUS
in children under 5 was 5.8 per 105 in 1988 and
2.1 per 105 in 1994–95.6 40 In the later study,
one HUS case was reported for every 4.3–5.2
cases of STEC infection. This greatly overesti-
mates the ratio of HUS to gastroenteritis as
many cases of STEC induced gastroenteritis
are unrecognised. This is borne out by a spate
of recent outbreaks of STEC O157:H7 diar-
rhoea in Japan aVecting 9845 children, of
whom 149 developed HUS.41
Previous studies suggest a summer peak of
STEC infection and HUS.8 Overall our study
showed a seasonal (summer) peak in incidence.
However, when analysed by individual year, a
summer peak in sporadic HUS occurred only
in the year of the outbreak. Interestingly, this
increase was Australia wide and not restricted
to the area of the outbreak. Further, the
outbreak cases occurring at this time were
microbiologically distinct from sporadic cases.
This suggests that climatic or environmental
factors operating throughout the country may
have contributed to a high background inci-
dence of STEC infection during this period,
caused by a variety of STEC, and also
increased the risk of an outbreak.
Comparison of sporadic and outbreak
groups indicates the outbreak strain was
associated with more severe disease at presen-
tation, but the reason for this is unclear. Epide-
miological studies suggest the young and
elderly have increased susceptibility to diar-
rhoea associated HUS but that older children
have a worse outcome.4 6 13 In this study,
outbreak patients were previously well but sig-
nificantly older than those with sporadic HUS.
This may reflect the fact that younger children
are less likely to eat fermented sausage. While
this study concurs with previous studies in
finding that a short diarrhoea prodrome and
bloody diarrhoea were indicative of more
severe disease, there was no association be-
tween neutrophil count and severity.3 11 42 43
Inoculum size may also be important in deter-
mining disease severity, although the South
Australian data showed low numbers of the
causative agent in the food vehicle, suggesting
that this was not the explanation in this
outbreak.23
Microbial factors are likely to be important
determinants of disease severity. In HUS, Stx is
responsible for microvascular injury causing
bloody diarrhoea and the systemic manifesta-
tions.7 29 The extent of damage may relate to
the amount of toxin absorbed, toxin type (Stx1
or Stx2) or subtype, and/or unrecognised host
susceptibility factors.7 Expression of the eae
gene is required for bacterial production of
intimin, an outer membrane protein involved
in the attachment of the STEC to epithelial
cells.7 STEC frequently produce enterohemo-
lysin but the roles of this and other plasmid
encoded factors in disease are unknown.44 The
O111:H− strains, which caused the outbreak
and those found to be associated with sporadic
HUS, exhibited all the pathogenicity traits
described above. However, comparison of out-
break O111:H− isolates with several O111:H−
isolates from sporadic cases revealed diVer-
ences in phage type and DNA restriction frag-
ment length polymorphism, indicating that dif-
ferent O111:H− strains were responsible for
outbreak and sporadic HUS. Genetic diVer-
ences in the outbreak strain may contribute to
diVerences in virulence by virtue of the
presence of currently unknown virulence
determinants or of diVerent quantities of
known determinants. A recent Minnesota
study reported that molecular subtyping of
strains isolated from the local community
allowed the authors to identify mini outbreaks
which would not have been recognised with
standard microbial characterisation.40 Molecu-
lar subtyping is also useful for O111 STEC and
may provide a mechanism to identify strains
with diVerent degrees of virulence.
In this study, several non-O157:H7 strains
were identified in children with HUS, as previ-
ously recognised.18 21 22 25 Apart from O111,
only one of these produced both Stx1 and Stx2.
Three strains lacked the eae gene and two of
these were negative for enterohemolysin. The
aetiological role of such strains in HUS is open
to question, given that Stx1 and Stx2 are
encoded by somewhat promiscuous bacteri-
ophages which are readily transmitted between
diVerent strains of E coli.45 Thus, the ability to
produce Stx may be acquired by a relatively
harmless E coli resident in the intestinal tract
from a virulent STEC strain that was not
detected when the stool sample was taken.45 In
such cases serological investigation may shed
light on the aetiological agent by permitting
detection of antibodies to O antigens associ-
ated with the most frequent STEC O sero-
groups. This applied to four patients in this
study who were culture negative, but displayed
increased antibody titres to O157. Detection of
antibodies to Stx1 and Stx2,46 as well as to
intimin or functionally related, chromosomally
encoded proteins,47 enterohemolysin,48 and
flagella antigens may also provide useful retro-
spective information about the causative or-
ganism in culture negative patients. In this
study, the relatively low isolation rate (40%) of
STEC overall and of O157 strains in particu-
lar, from children with sporadic HUS may have
been a result of an undue delay in obtaining
samples for culture and transporting them to
the laboratory. Isolation rates of O157 strains
could conceivably have been improved by
selective enrichment, for example, by using
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immunomagnetic enrichment of faecal sam-
ples. Such strategies, however, would probably
have biased the data against non-O157 strains.
Medium term prognosis for diarrhoea asso-
ciated HUS in this study was similar to that
reported previously.4 5 Despite diVerences in
disease severity at presentation, follow up at 12
months indicated no significant diVerences
between outbreak and sporadic groups in rates
of chronic renal failure and end stage renal
failure. Mortality rates and prevalence of
hypertension, central nervous, and gastro-
intestinal complications in groups were also
similar.
In conclusion, nationwide HUS surveillance
through APSU, which is ongoing, provided
new information on the burden of HUS in
Australia and enabled linkage of epidemiologi-
cal, clinical, and microbiological data. We
identified 12 non-O157:H7 strains of STEC
associated with HUS including one O111:H−,
which was responsible for an outbreak. The
heterogeneity of isolates and the absence of
O157:H7 diVer from the current situation in
most countries. The observation that O157
isolates were non-motile and failed to produce
the full array of virulence associated determi-
nants suggests a comparatively reduced viru-
lence of Australian representatives of this sero-
group and may explain their failure to become
established in this country. This study was
unique in allowing comparison of outbreak and
sporadic diarrhoea associated HUS occurring
during surveillance and indicates that outbreak
cases had more severe disease at presentation.
Examination of microbial pathogenicity factors
of isolated strains supported the notion that the
outbreak of HUS may have been associated
with a more virulent strain of STEC than
strains causing sporadic disease.
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